Intelligencia

Intelligencia AI is a B2B software vendor offering an AI-driven platform that revolutionizes drug development. It leverages advanced machine learning and predictive analytics to assess, quantify, and significantly reduce the inherent risks in clinical trials. The platform provides precise, unbiased assessments of a drug's probability of success (PoS) and phase transition probabilities, enabling pharmaceutical and biotechnology companies to make data-driven decisions, optimize research processes, accelerate clinical development, and bring novel therapies to market faster and more efficiently. The company's solutions support R&D, clinical development, portfolio management, and business development.

See website
See website
Audience members with pink lanyards attentively watching and smiling during a presentation.

Vendor Details

Leveraging AI to de-risk and accelerate drug development by improving the probability of success in clinical trials.

Claim Profile
Claim Profile
Pillar
Trends & Foresight
Primary SITech Category
Trends Prediction
2nd SubCat
Trends Analytics
3rd SubCat
Tech Category
SaaS, Cloud, Machine Learning, Predictive Analytics, Deep Learning, Large Language Models
Data Coverage
Healthcare & Medical Data
Data Sources
No items found.
AI/GenAI Type
Predictive AI & Analytics
Natural Language & Conversational AI
Geographic Coverage
No items found.
Specialized Industries
Healthcare & Life Sciences
Pharmaceutical
HQ Location
North America

Company Info

office@intelligencia.ai

Intelligencia AI is a B2B software vendor offering an AI-driven platform that revolutionizes drug development. It leverages advanced machine learning and predictive analytics to assess, quantify, and significantly reduce the inherent risks in clinical trials. The platform provides precise, unbiased assessments of a drug's probability of success (PoS) and phase transition probabilities, enabling pharmaceutical and biotechnology companies to make data-driven decisions, optimize research processes, accelerate clinical development, and bring novel therapies to market faster and more efficiently. The company's solutions support R&D, clinical development, portfolio management, and business development.